18-3149136-ACTT-A
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_003803.4(MYOM1):c.1900+6_1900+8delAAG variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000114 in 1,613,726 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.00063   (  0   hom.,  cov: 31) 
 Exomes 𝑓:  0.000060   (  0   hom.  ) 
Consequence
 MYOM1
NM_003803.4 splice_region, intron
NM_003803.4 splice_region, intron
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  0.139  
Publications
0 publications found 
Genes affected
 MYOM1  (HGNC:7613):  (myomesin 1) The giant protein titin, together with its associated proteins, interconnects the major structure of sarcomeres, the M bands and Z discs. The C-terminal end of the titin string extends into the M line, where it binds tightly to M-band constituents of apparent molecular masses of 190 kD (myomesin 1) and 165 kD (myomesin 2). This protein, myomesin 1, like myomesin 2, titin, and other myofibrillar proteins contains structural modules with strong homology to either fibronectin type III (motif I) or immunoglobulin C2 (motif II) domains. Myomesin 1 and myomesin 2 each have a unique N-terminal region followed by 12 modules of motif I or motif II, in the arrangement II-II-I-I-I-I-I-II-II-II-II-II. The two proteins share 50% sequence identity in this repeat-containing region. The head structure formed by these 2 proteins on one end of the titin string extends into the center of the M band. The integrating structure of the sarcomere arises from muscle-specific members of the superfamily of immunoglobulin-like proteins. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008] 
MYOM1 Gene-Disease associations (from GenCC):
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP6
Variant 18-3149136-ACTT-A is Benign according to our data. Variant chr18-3149136-ACTT-A is described in ClinVar as Likely_benign. ClinVar VariationId is 454433.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS2
High AC in GnomAd4 at 96 AD gene. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| MYOM1 | ENST00000356443.9  | c.1900+6_1900+8delAAG | splice_region_variant, intron_variant | Intron 13 of 37 | 1 | NM_003803.4 | ENSP00000348821.4 | |||
| MYOM1 | ENST00000261606.11  | c.1900+6_1900+8delAAG | splice_region_variant, intron_variant | Intron 13 of 36 | 1 | ENSP00000261606.7 | 
Frequencies
GnomAD3 genomes   AF:  0.000631  AC: 96AN: 152196Hom.:  0  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
96
AN: 
152196
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000189  AC: 47AN: 249264 AF XY:  0.000133   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
47
AN: 
249264
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000602  AC: 88AN: 1461412Hom.:  0   AF XY:  0.0000523  AC XY: 38AN XY: 727012 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
88
AN: 
1461412
Hom.: 
 AF XY: 
AC XY: 
38
AN XY: 
727012
show subpopulations 
African (AFR) 
 AF: 
AC: 
72
AN: 
33476
American (AMR) 
 AF: 
AC: 
4
AN: 
44720
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26134
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39692
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
86250
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53398
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
6
AN: 
1111618
Other (OTH) 
 AF: 
AC: 
5
AN: 
60356
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.422 
Heterozygous variant carriers
 0 
 4 
 9 
 13 
 18 
 22 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 4 
 8 
 12 
 16 
 20 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.000630  AC: 96AN: 152314Hom.:  0  Cov.: 31 AF XY:  0.000671  AC XY: 50AN XY: 74496 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
96
AN: 
152314
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
50
AN XY: 
74496
show subpopulations 
African (AFR) 
 AF: 
AC: 
92
AN: 
41582
American (AMR) 
 AF: 
AC: 
2
AN: 
15302
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5182
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10618
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
68016
Other (OTH) 
 AF: 
AC: 
1
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.492 
Heterozygous variant carriers
 0 
 8 
 16 
 24 
 32 
 40 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Hypertrophic cardiomyopathy    Benign:1 
Dec 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.